Holen Sie sich die Stockscreener-App
4.55
5.36%
0.07
Schlusskurs vom Vortag:
$4.48
Offen:
$4.47
24-Stunden-Volumen:
1,309
Relative Volume:
0.06
Marktkapitalisierung:
$3.61M
Einnahmen:
$208.50K
Nettoeinkommen (Verlust:
$-6.85M
KGV:
-0.0654
EPS:
-69.6012
Netto-Cashflow:
$-2.92M
1W Leistung:
+12.38%
1M Leistung:
-5.60%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.47
$5.0433
1-Wochen-Bereich:
$4.18
$4.71
52-Wochen-Spanne:
$3.38
$7.56
Nexentis Technologies Inc Stock (NXTS) Company Profile
Firmenname
Nexentis Technologies Inc
Sektor
Branche
Telefon
972544561349
Adresse
156 FIFTH AVENUE 10TH FLOOR, NEW YORK
Compare NXTS vs CTVA, NTR, CF, ICL, MOS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NXTS
Nexentis Technologies Inc
|
4.945 | 3.23M | 208.50K | -6.85M | -2.92M | -69.60 |
CTVA
Corteva Inc
|
79.50 | 53.21B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
70.00 | 33.66B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
120.05 | 18.70B | 7.41B | 2.12B | 1.62B | 11.13 |
ICL
Icl Group Ltd
|
6.56 | 8.34B | 7.15B | 280.00M | 137.88M | 0.1749 |
MOS
Mosaic Company
|
22.76 | 7.15B | 12.05B | 575.40M | -534.60M | 1.6871 |
Nexentis Technologies Inc Aktie (NXTS) Neueste Nachrichten
Nexentis Technologies (NXTS) Earnings Outlook: Key Metrics for Q2 2025Retail Trader Picks - Newser
Nexentis subsidiary achieves drug discovery milestone By Investing.com - Investing.com South Africa
Nexentis Technologies says MitoCareX Bio achieves drug discovery milestone - TipRanks
Nexentis subsidiary reaches drug discovery milestone - Investing.com
Nexentis subsidiary reaches drug discovery milestone By Investing.com - Investing.com Canada
Nexentis subsidiary achieves drug discovery milestone - Investing.com
Nexentis develops new molecule to potentially tackle hard-to-treat cancers - Stock Titan
Nexentis Technologies (NASDAQ: NXTS) posts Q1 2026 loss, flags going concern risk - Stock Titan
Nexentis Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Nexentis Technologies Inc. Announces Drug Discovery Milestone Achieved by MitoCareX Utilizing MITOLINE® Platform - Quiver Quantitative
Nexentis Technologies Announces Optimization of Hit - GlobeNewswire
Nexentis Technologies Inc. (NXTS) - Zacks Investment Research
Number of shareholders of Nexentis Technologies Inc. – NASDAQ:NXTS - TradingView
Nexentis Technologies Secures US Trademark Approval for MitoCareX Algorithm Platform MITOLINE - ChemAnalyst
Nexentis Technologies stock jumps on trademark approval - Investing.com
Nexentis subsidiary receives U.S. trademark for drug platform By Investing.com - Investing.com South Africa
Nexentis Technologies stock jumps on trademark approval By Investing.com - Investing.com Nigeria
Nexentis subsidiary receives U.S. trademark for drug platform - Investing.com
Drug discovery firm secures U.S. trademark for its MITOLINE platform - Stock Titan
Nexentis Technologies Announces U.S. Trademark Registration - GlobeNewswire
NXTS (Nexentis Technologies) falls 2.62% after Q2 2025 earnings with no consensus performance benchmarks available.FCF Yield - newser.com
Nexentis Shareholders Approve Reverse Split and Financing Flexibility - The Globe and Mail
Shareholders back Nexentis (NITO) reverse split and equity financing plans - Stock Titan
[EFFECT] Nexentis Technologies Inc. SEC Filing - Stock Titan
NXTS Price History for Nexentis Technologies Stock - Barchart.com
Nexentis Technologies (NXTS) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
NXTS News | NEXENTIS TECHNOLOGIES INC (NASDAQ:NXTS) - ChartMill
Nexentis Technologies Inc. (NXTS) Cash Equivalents (Quarterly) - Zacks Investment Research
Nexentis Technologies (NXTS) Stock: Breaking Downtrend? (Soars) 2026-04-20Beta Signals - Cổng thông tin điện tử tỉnh Lào Cai
Top Nexentis Technologies (NXTS) Competitors 2026 - MarketBeat
Nexentis Technologies (NXTS) Earnings Date and Reports 2026 - MarketBeat
Nexentis Technologies Incmay offer up to $100 million of securitiesSEC filing - marketscreener.com
[S-3] Nexentis Technologies Inc. Shelf Registration Statement - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Nexentis Technologies (NXTS) Institutional Ownership 2026 - MarketBeat
Nexentis Technologies (NXTS) Stock Price, News & Analysis - MarketBeat
Debt to assets ratio of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Total liabilities of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Revenue per share of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc. Statistics – LS:A425ME - TradingView
Non-controlling/minority interest of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Enterprise value to EBITDA ratio of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Total debt per share of Nexentis Technologies Inc. – LS:A425ME - TradingView
Net debt of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Tangible book value per share of Nexentis Technologies Inc. – LS:A425ME - TradingView
Preferred dividends of Nexentis Technologies Inc. – LS:A425ME - TradingView
EBIT of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc. Balance Sheet – LS:A425ME - TradingView — Track All Markets
Gross profit of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc. Cash Flow – LS:A425ME - TradingView — Track All Markets
Dilution adjustment of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Finanzdaten der Nexentis Technologies Inc-Aktie (NXTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
3.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):